Chemicals Dragged Down, Medtech Lifted Up

Analysts are making fresh calls across sectors this Monday. Two chemicals giants took hits. Target prices fell for both DOW and LYB. Dow's average target slipped to $41.50. LyondellBasell's dropped to $78.41. Both names sit in a sector facing margin pressure from weak global demand.

Medical devices moved the other way. Edwards Lifesciences saw its consensus target nudge up to $97.31. The heart valve maker carries a $52bn market cap. Short interest is just 2.1% of free float — bears are not piling in.

The most striking action came at Honeywell. An analyst removed their recommendation entirely. The consensus target dropped sharply to $229, down from a prior $486. That is a dramatic revision for a $147bn industrial giant. It likely reflects Honeywell's ongoing breakup into three separate businesses.

Capital One picked up a target upgrade to $256. KKR also gained, with its target moving to $126. Both financials benefit from the current rate environment.

Walt Disney got a target bump to $129.94. The stock carries 26 sell recommendations — the bullish camp remains thin despite recent streaming gains.